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Kawasaki disease (KD) is an acute vasculitis of young children that can be complicated by coronary artery
abnormalities. Recent findings suggest that a superantigen(s) may play an important role in stimulating the
immune activation associated with the disease, although the origin of this superantigen(s) is unclear. Staph-
ylococcus aureus, isolated from the rectum or pharynx of patients with KD, secretes toxic shock syndrome toxin
1 (TSST-1). The KD isolates express low levels of other exoproteins compared to isolates from patients with
toxic shock syndrome (TSS). Thus, it was previously suggested that the KD isolates may be defective in the
global regulatory locus agr (for accessory gene regulator), which positively regulates these factors (D. Y. M.
Leung et al., Lancet 342:1385–1388, 1993). Here we describe another characteristic of KD isolates. When con-
sidered collectively, the KD isolates were found to express higher levels of staphylococcal protein A than the
TSS isolates, another characteristic of an agr-defective phenotype. This correlated with a higher level of spa
mRNA in these isolates. In contrast, the KD and TSS isolates expressed comparable levels of TSST-1, consist-
ent with previous findings (D. Y. M. Leung et al., Lancet 342:1385–1388, 1993). Analysis of RNAIII transcript
levels and nucleotide sequence analysis of the RNAIII-coding region suggested that the KD isolates are not
defective in RNAIII, the effector molecule of the agr regulatory system. However, induction of RNAIII tran-
scription in the KD isolates did not result in a dramatic decrease in the amount of spa mRNA, as has been
reported for other strains (F. Vandenesch, J. Kornblum, and R. P. Novick, J. Bacteriol. 173:6313–6320, 1991).
Kawasaki disease (KD) is an acute illness of early childhood
characterized by fever, induration and erythema of the hands
and feet, inflammation of the mucous membranes, polymor-
phous skin rash, and cervical lymphadenopathy (23). As a
complication of this multisystem vasculitis, coronary artery an-
eurysms or ectasias occur in approximately 25% of untreated
patients (22). In the United States and Japan, KD is currently
the leading cause of acquired heart disease in children. A
number of observations suggest that immune mechanisms play
an important role in the pathogenesis of the disease. In par-
ticular, acute KD is characterized by significant immune acti-
vation. Increased numbers of circulating activated T cells, B
cells, and macrophages/monocytes lead to high levels of circu-
lating cytokines and to the production of cytotoxic antibodies
directed against vascular endothelial cell antigens (14, 30–32).
These immunologic features, particularly the activation of T
cells and macrophages, are characteristic of diseases which are
caused by microbial superantigens (25). Indeed, the clinical
symptoms and epidemiology of KD are highly suggestive of an
infectious disease, overlapping with staphylococcal and strep-
tococcal scarlet fevers and toxic shock syndromes (TSSs).
Recently, it was suggested that staphylococcal toxic shock
syndrome toxin 1 (TSST-1) and streptococcal pyrogenic exo-
toxins might contribute to KD (34). In a blinded, controlled
study, 13 of 16 KD patients were found to be infected with
TSST-1-producing (n 5 11) or streptococcal pyrogenic exo-
toxin C-producing (n 5 2) bacteria, compared with only 1 of 15
febrile controls. We proposed that TSST-1-producing Staphy-
lococcus aureus and streptococcal pyrogenic exotoxin C-pro-
ducing streptococci could account for the selective expansion
of Vb2-expressing T cells in the blood and tissues of patients
with acute KD, which has now been reported by three inde-
pendent groups (1, 2, 11, 33, 50). In a follow-up multicenter
study, it was found that TSST-1-producing S. aureus could be
isolated from 31 of 32 patients with acute KD (36).
Staphylococcal protein A (SpA) is produced by over 95% of
S. aureus strains and has the ability to bind to the Fc region of
immunoglobulin G (IgG) in most mammalian species. This
protein has been shown to inhibit opsonization and phagocy-
tosis of staphylococci in vitro, a factor that may contribute to
the virulence of this organism in vivo (15, 42, 43). SpA also
exhibits diverse immunobiological properties, including an
ability to activate B cells (B-cell superantigen) and comple-
ment (17, 26–28, 48). Interestingly, these laboratory parame-
ters of immune activation have been reported during acute KD
(24, 29). Thus, together with T-cell superantigens, such as
TSST-1, SpA could account for at least some of the immune
activation associated with this disease.
It was recently observed that S. aureus isolated from KD
patients produced less lipase, hemolysin, and protease than
isolates from TSS and other skin diseases. However, the KD
isolates did not produce particularly low levels of TSST-1 (34).
The expression of these exoproteins is controlled by global
regulatory loci, including agr (for accessory gene regulator)
(38, 44). This locus consists of two divergent transcripts,
RNAII and RNAIII, driven by two distinct promoters, P2 and
P3, respectively (40). RNAIII is the effector molecule of this
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regulatory system. During the postexponential and stationary
phases of growth, this molecule upregulates the expression of
various exoproteins and downregulates the expression of fac-
tors such as SpA, the fibronectin-binding proteins, and coagu-
lase (20, 41). In bona fide agr-defective mutants, there is a lack
of RNAIII expression, low expression levels of the positively
regulated extracellular factors such as hemolysins, proteases,
and TSST-1, and high expression levels of the negatively reg-
ulated factors, such as SpA. It has thus been speculated that
the KD isolates may represent a new clone of TSST-1-secreting
S. aureus which has a partially defective agr locus, or these
isolates may be bona fide agr-defective mutants which have
reverted in their ability to express TSST-1 (34).
In this study, we further characterized the KD isolates by
examining the level of SpA expressed by these isolates com-
pared to TSS isolates. We report that, when considered as a
group, the KD isolates express significantly higher levels of cell
wall-associated and extracellular SpA than TSS isolates, an-
other characteristic of an agr-defective phenotype. However,
consistent with previous observations, no difference was seen
in the level of TSST-1 expressed by the two groups of isolates.
We investigated the possibility that the KD isolates may be
partially defective in their agr loci by analyzing spa and RNAIII
transcription levels and by nucleotide sequence analysis of the
RNAIII-coding region.
MATERIALS AND METHODS
Bacterial strains and growth conditions. S. aureus strains Cowan I and Wood
46 were obtained from the American Type Culture Collection (Rockville, Md.).
S. aureus strains 8325-4, RN4282, and RN4256 (RN4282 agrA::Tn551) were
kindly provided by R. P. Novick (Public Health Research Institute, New York,
N.Y.). TSST-1-expressing S. aureus isolates were obtained from either pharyn-
geal or rectal swabs of 21 patients with acute KD. Each of these patients fulfilled
the diagnostic guidelines of the American Heart Association (3). TSST-1-ex-
pressing vaginal isolates of S. aureus were obtained from 12 patients with men-
strual TSS. S. aureus strains were grown in tryptic soy broth (TSB). Escherichia
coli JM101 (51) was used for plasmid DNA transformations and was grown in
Luria-Bertani broth, containing 100 mg of ampicillin per ml when appropriate.
Analysis of cell wall-associated SpA expression by flow cytometry. Overnight
cultures were diluted 1:50 in 5 ml of fresh TSB and were grown with shaking at
37°C to early and late exponential phases (Fig. 1A, t1 and t2, respectively). All the
isolates had similar growth rates and equivalent optical density at 600 nm
(OD600) values at each 1-h time point. Cells were pelleted at 2,500 3 g for 10 min
at 4°C and then resuspended and blocked in staining solution (5% fetal calf
serum, 0.1% intravenous immunoglobulin, 0.02% sodium azide in phosphate-
buffered saline [PBS]) for 1 h at 4°C. Following the addition of 0.5 mg of bio-
tinylated anti-SpA monoclonal antibody (MAb) (Sigma, St. Louis, Mo.), the cells
were incubated for a further 30 min at 4°C. Cells were then washed twice in a
wash solution (2% fetal calf serum, 0.02% sodium azide in PBS) and resus-
pended in staining solution. Phycoerythrin-conjugated streptavidin (Southern
Biotechnology Associates, Inc., Birmingham, Ala.) was added, and the cells were
incubated for 30 min at 4°C. Cells were then washed once in wash solution and
twice in 0.02% sodium azide in PBS. Stained cells were fixed with 1% methanol-
free formaldehyde in PBS (Polysciences, Inc., Warrington, Pa.) and analyzed
with a Becton Dickinson FACScalibur, by using Cellquest software. Relative cell
wall-associated SpA expression was measured by mean fluorescence intensity
(MFI) with the anti-SpA MAb.
Quantification of extracellular SpA expression by ELISA. Extracellular SpA
production was quantified by enzyme-linked immunosorbent assay (ELISA), as
previously described (13). Overnight cultures were diluted 1:50 in 5 ml of fresh
TSB and were grown with shaking at 37°C to early and late exponential phases
(Fig. 1A, t1 and t2, respectively). All the isolates had similar growth rates and
equivalent OD600 values at each time point. Cells were pelleted at 2,500 3 g for
10 min at 4°C, and the supernatants were retained for analysis. Each well of a
96-well polystyrene plate (Corning, New York, N.Y.) was coated with 50 ml of a
solution containing 10 mg of anti-SpA MAb (Sigma) per ml of 0.1 M NaHCO3
buffer (pH 8.2) for 18 h at 4°C. The wells were washed twice with PBS (pH 7.2)
containing 0.05% Tween 20 (PBS/T) and then blocked with 200 ml of 1% bovine
serum albumin (BSA) in PBS/T per well for 2 h at room temperature. After
washing twice with PBS/T, 100 ml of a 1:10 dilution (in PBS/T containing 1%
BSA) of each supernatant was added to the wells and incubated for 18 h at 4°C.
The wells were washed four times with PBS/T, 100 ml of biotinylated anti-SpA
MAb (Sigma) in PBS/T was added to each well, and the plate was incubated for
45 min at room temperature. After washing six times with PBS/T, 100 ml of
avidin-peroxidase conjugate (Sigma) in PBS/T-BSA was added to each well, and
the plate was incubated for 30 min at room temperature. Wells were washed
eight times with PBS/T, 100 ml of ABTS [2,29-azinobis(3-ethylbenzthiazolinesul-
fonic acid] peroxidase substrate (Kirkegaard & Perry Laboratories, Gaithers-
burg, Md.) was added to each well, and the plate was incubated at room tem-
perature in the dark. After 9 min, the reaction was quenched by adding 100 ml of
stop solution to each well. The OD405 was determined. A standard curve was
prepared with known concentrations of a commercial preparation of SpA, pu-
rified from the cell wall of S. aureus Cowan I (Sigma).
Quantification of TSST-1 expression by ELISA. Overnight cultures were di-
luted 1:50 in 5 ml of fresh TSB and were grown with shaking at 37°C to late
exponential phase (Fig. 1A, t2). All the isolates had similar growth rates and
equivalent OD600 values at each time point. Cells were pelleted at 2,500 3 g for
10 min at 4°C. The supernatants were diluted 1:4 in PBS/T, normal rabbit serum
was added to a final concentration of 1% (vol/vol), and the samples were incu-
bated for 15 min at room temperature. Each well of a 96-well polystyrene plate
(NUNC, Inc., Naperville, Ill.) was coated overnight with 100 ml of a solution
containing 10 mg of anti-TSST-1 antibodies (Toxin Technology, Sarasota, Fla.)
per ml of 0.1 M NaHCO3 buffer (pH 8.2) at 37°C. The plate was then washed
twice with PBS/T and blocked with PBS/T for 30 min at room temperature. After
washing twice with PBS/T, 100 ml of each diluted supernatant sample was added
to the wells, and the plate was incubated for 2 h at 37°C. The plate was washed
three times with PBS/T and then incubated with horseradish peroxidase-conju-
gated anti-TSST-1 antibodies (Toxin Technology) for 1 h at 37°C. Wells were
washed 10 times with PBS/T, 100 ml of ABTS peroxidase (Sigma) was added to
each well, and the plate was incubated at room temperature. After 15 min, the
reaction was quenched by adding 50 ml of stop solution to each well. OD405 was
determined. A standard curve was prepared with known concentrations of pu-
rified TSST-1 (Toxin Technology).
Isolation of RNA and Northern hybridization analysis. Total cellular RNA
was isolated from cultures grown to early and late exponential phases (Fig. 1A,
t1 and t2, respectively) by using the RNeasy Mini kit (Qiagen Inc., Santa Clarita,
Calif.). All the isolates had similar growth rates and equivalent OD600 values at
each time point. Ten micrograms of each RNA sample (as determined by mea-
suring the OD260) was resolved by 1.2% agarose-formaldehyde gel electrophore-
sis. RNA Millenium Markers (Ambion Inc., Austin, Tex.) were used as size
standards. RNA was transferred onto a Hybond N1 membrane (Amersham Life
Science, Inc., Arlington Heights, Ill.) and was hybridized with radioactively
labeled DNA probes at 42°C, as described by Sambrook et al. (45). Probes were
random primer labeled with [a-32P]dCTP to a specific activity of 1 3 108 to 5 3
108 cpm/mg by using the RadPrime DNA labeling system (Gibco BRL, Grand
Island, N.Y.). Probe DNA for the spa and RNAIII transcripts was amplified by
PCR from the chromosomes of strains Cowan I and 8325-4, respectively, as fol-
lows: spa, a 1.346-kb fragment (nucleotide [nt] 771 to 2117, according to Shuttle-
worth et al. [46]) by using the primers 59-TTATATCTGGTGGCGTAACACC
TGC-39 and 59-ATGCTTGAGCTTTGTTAGCATCTGC-39, and RNAIII, a
945-bp fragment (nt 581 to 1526, according to Janzon et al. [21]) containing the
entire RNAIII-coding sequence and the 59 half of agrB by using the primers
59-AAATACATAGCACTGAGTCCAAGG-39 and 59-TTTAATAAGTCGCA
CAGGAATGGG-39. After hybridization, membranes were washed twice in a
solution containing 23 SSC (13 SSC is 0.15 M NaCl plus 0.015 M sodium
citrate) and 0.1% sodium dodecyl sulfate (SDS) at 65°C and once in 0.13
SSC–0.1% SDS at 65°C, for 30 min each time. Membranes were exposed to
Kodak X-Omat AR film at 280°C for various lengths of time.
Molecular cloning and sequencing. An 862-bp fragment containing the entire
RNAIII-coding region and approximately 160 bp of upstream sequence (nt 314
to 1175, according to Janzon et al. [21]) was amplified by PCR from the chro-
mosomes of strain 8325-4, five KD isolates (Yeh, KD1, KD6, KD-ATK, and
Thomas), and two TSS isolates (MN8 and FRI 1169) by using Pfu DNA poly-
merase (Stratagene, La Jolla, Calif.) and the primers 59-ACCTTTTCCAAC
ATTAGACTTATT-39 and 59-TTATTTCTCTTTTGAAGATACGTGG-39. The
products were cloned into the TA cloning vector pCR2.1 (Invitrogen, San Diego,
Calif.). The constructs were purified with the QIAprep Spin Miniprep kit (Qia-
gen) and were sequenced in both directions with the Taq DyeDeoxy Terminator
Cycle Sequencing kit (Perkin-Elmer Applied Biosystems, Foster City, Calif.),
M13 reverse and T7 primers, and an automated DNA sequencer (model 377;
Perkin-Elmer Applied Biosystems) at the University of Texas—Houston Medical
School Molecular Genetics Core Facility. Nucleotide sequences were analyzed
with SeqEd software (Perkin-Elmer Applied Biosystems).
RESULTS
Determination of cell wall-associated SpA expression levels.
The levels of cell wall-associated SpA produced by early- and
late-exponential-phase (Fig. 1A, t1 and t2, respectively) cul-
tures of the KD and TSS isolates were compared by flow
cytometry, by using a biotinylated anti-SpA MAb and phyco-
erythrin-conjugated streptavidin. The MFI observed gives a
relative measure of the cell wall-associated SpA expressed by
each isolate (Fig. 2). Strains Cowan I and Wood 46 were
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included in this study as examples of strains which express high
and very low levels of SpA, respectively. Strain RN4256 was
also included as an example of an agr mutant that lacks
RNAIII, a negative regulator of spa gene transcription. As
anticipated, strains Cowan I and RN4256 produced signifi-
cantly higher levels of cell wall-associated SpA than strain
Wood 46 at both growth phases analyzed. When compared
collectively, the KD isolates (n 5 14) expressed significantly
higher levels of cell wall-associated SpA than the TSS isolates
(n 5 11) at the early exponential growth phase (MFI of
950.04 6 349.38 versus 95.98 6 58.79; P , 0.05, Student’s t
test). The same result was observed for late-exponential-phase
cultures of the KD and TSS isolates (MFI of 1,597.07 6 368.70
versus 228.99 6 134.90; P , 0.05, Student’s t test).
Production of extracellular SpA. The levels of extracellular
SpA secreted by early- and late-exponential-phase cultures
(Fig. 1A, t1 and t2, respectively) of the KD and TSS isolates
were determined by ELISA (Fig. 3). Again, strains Cowan I,
Wood 46, and RN4256 were included in the study as controls.
When compared collectively, the KD isolates (n 5 21) were
found to secrete significantly higher levels of SpA than the TSS
isolates (n 5 12) at both growth phases analyzed (0.54 6 0.10
versus 0.28 6 0.22 mg/ml for early-exponential-phase cultures
and 1.22 6 0.42 versus 0.51 6 0.35 mg/ml for late-exponential-
phase cultures; P , 0.05, Student’s t test). However, when
considered individually, a few TSS isolates were observed to
express high levels of extracellular SpA comparable to the KD
isolates.
Production of TSST-1. The amounts of TSST-1 secreted by
late-exponential-phase cultures (Fig. 1A, t2) of the KD (n 5
19) and TSS (n 5 12) isolates were measured by ELISA (Fig.
4). The level of TSST-1 secretion was highly variable among
FIG. 1. (A) Growth curve of S. aureus Cowan I. Growth curves obtained for the KD and TSS isolates were very similar. Time points (t1 and t2 represent early and
late exponential phases, respectively) at which samples were taken for isolation of total RNA for Northern hybridization analysis are indicated by the arrows. Ten
micrograms of total RNA was loaded in each well and probed for the (B) spa and (C) RNAIII transcripts, as described in the text. Samples were loaded as follows:
lane 1, strain RN4282; lane 2, strain RN4256 (strain RN4282 agrA::Tn551); lanes 3 to 7, KD isolates (strains Yeh, KD1, KD6, KD-ATK, and Thomas, respectively);
lanes 8 to 11, TSS isolates (strains MN8, FRI 1169, L. Park TN 1986, and K. Johnson MN 1985, respectively); lane 12, strain Cowan I; and lane 13, strain Wood 46.
This analysis was performed in duplicate, with similar results.
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individual isolates, ranging from 0.25 to 30.0 ng/ml. Further-
more, in contrast to cell wall-associated or extracellular SpA,
there was no statistically significant difference in the levels of
TSST-1 secreted by the KD or TSS groups of isolates at this
growth phase (8.55 6 5.41 and 10.00 6 9.39 ng/ml, respective-
ly).
Analysis of spa and RNAIII transcript levels. To investigate
the possibility that KD isolates may have a partially defective
agr locus, the levels of spa and RNAIII transcripts in early- and
late-exponential-phase cultures (Fig. 1A, t1 and t2, respec-
tively) of the KD (n 5 9) and TSS (n 5 11) isolates were
compared by Northern hybridization analysis. Strains Cowan I,
Wood 46, and RN4282 and its isogenic, agr-negative mutant,
RN4256, were included in the study as controls. The results
obtained for some of the isolates analyzed are shown in Fig. 1B
and 1C. High levels of spa mRNA (ca. 1.8 kb) were detected at
both growth phases in all the KD isolates analyzed (Fig. 1B,
lanes 3 to 7, and data not shown), strain RN4256 (Fig. 1B, lane
2), and strain Cowan I (Fig. 1B, lane 12). This is consistent with
the finding that these strains express high levels of SpA. A
similar result was observed for a few TSS isolates (Fig. 1B,
lanes 10 and 11, and data not shown). These TSS isolates
expressed high levels of SpA, comparable to the KD isolates.
The spa mRNA was undetectable or barely detectable in the
remaining TSS isolates analyzed (Fig. 1B, lanes 8 and 9, and
data not shown), strain RN4282 (Fig. 1B, lane 1), and strain
Wood 46 (Fig. 1B, lane 13). This is consistent with the obser-
vation that SpA is expressed at significantly lower levels by
these strains.
The RNAIII transcript (ca. 510 bp) was detected in both
early- and late-exponential-phase cultures of all the strains
analyzed, except for strains RN4256 and Cowan I (Fig. 1C and
data not shown). This is consistent with strain RN4256 being
an agr-defective mutant. It also suggests that Cowan I has an
uncharacterized agr defect, which may explain the high level of
SpA expressed by this strain. The RNAIII transcript was more
abundant in the late-exponential-phase cultures of all the iso-
lates tested, consistent with previous reports on the regulation
of the expression of this factor. However, significantly less
RNAIII was detected in the early-exponential-phase cultures
of all the KD isolates and a few of the TSS isolates than of
strains RN4282, Wood 46, and the remaining TSS isolates.
Furthermore, an inverse correlation was observed between the
levels of the RNAIII and spa transcripts detected for each
strain at this growth phase. This is consistent with RNAIII
functioning as a negative regulator of spa gene transcription.
Interestingly, despite the elevated levels of RNAIII in the
late-exponential-phase cultures of the KD isolates and certain
TSS isolates, the amount of spa mRNA did not decrease dra-
matically in these isolates.
DNA sequence analysis of the RNAIII-coding region. Al-
though all the KD isolates analyzed express RNAIII, it is
possible that this transcript may not be functional in these
strains. To address this question, the DNA sequence of a ca.
860-bp chromosomal fragment encompassing the RNAIII
reading frame, the RNAIII P3 promoter, and the agr operon
P2 promoter of five KD isolates and strains MN8 and FRI 1169
(TSS isolates) was determined. Each sequence was identical
except that for strain FRI 1169 (data not shown). The se-
quences were compared to that published for strain 8325-4
(GenBank accession no. X17301), a well-characterized Agr1
strain. The FRI 1169 sequence was identical to this except for
a single nucleotide substitution 2 nt upstream from the
RNAIII transcriptional start site. The sequences of the other
FIG. 2. Cell wall-associated SpA expression by KD and TSS isolates of S. aureus. Relative expression of SpA was determined using flow cytometry by measuring
the MFI after incubation with biotinylated anti-SpA MAb and phycoerythrin-conjugated streptavidin, as described in the text. Each value represents the mean of
duplicate analyses on the same isolate during the early and late exponential growth phases (t1 and t2 in Fig. 1A, respectively). Strains RN4256, Cowan I, and Wood
46 were included in the study as controls. KD isolates were found to express significantly (P , 0.05) more SpA on their cell surface than TSS isolates as calculated by
Student’s t test.
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strains differed from that of strain 8325-4 in 10 nucleotide
positions. However, all of these substitutions were outside the
RNAIII-coding region and the 210 and 235 boxes of both the
P2 and P3 promoters. There were also two insertions in the
MN8/KD isolate sequence compared to strain 8325-4. A single
nucleotide insertion which was not predicted to affect the
RNAIII secondary structure was found at the 39 end of the
RNAIII-coding region (but outside the hld gene), and a 4-nt
insertion was found just downstream from the RNAIII tran-
scriptional termination site. Therefore, the sequence of the
RNAIII molecule appears to be highly conserved in all the
strains analyzed, with no apparent mutations that might affect
the functionality or transcription level of the molecule.
DISCUSSION
It has been previously reported that TSST-1-secreting
strains of S. aureus isolated from patients with KD exhibit an
unusual phenotype which distinguishes them from TSS iso-
lates, including the expression of lower levels of hemolyins,
lipase, and protease (34). In this study, we describe another
phenotype associated with KD isolates. When considered col-
lectively, these isolates were found to express significantly
more cell wall-associated and extracellular SpA than isolates
from patients with TSS. This correlated with a higher level of
spa mRNA expression in the KD isolates. Nonetheless, when
considered individually, a few TSS isolates which expressed
levels of spa mRNA and SpA comparable to the KD isolates
were observed. Thus, high levels of SpA expression are not
unique to the KD isolates but do appear to be a characteristic
phenotype of these strains. In contrast, the KD and TSS iso-
lates expressed comparable levels of TSST-1 in this study,
consistent with previous findings (34).
It was recently suggested that the KD isolates might have a
defective agr regulatory system that may be responsible for the
usual phenotype associated with these strains (34). The high
levels of SpA expressed by the KD isolates in this study are also
typical of agr-defective mutants. Interestingly, the agr locus is
genetically unstable in vitro (4, 37). Therefore, in this study, we
chose to investigate the possibility that the KD isolates may
have an agr defect. The agr locus consists of two divergent
transcripts, RNAII, which contains agrB, -D, -C, and -A, and
RNAIII, the effector molecule of the regulatory system (20,
41). The transcription of RNAIII is regulated by the agr system
itself, and RNAIII is not transcribed in mutants that have a
defect in any of the agr genes (40). In this study, all of the
isolates analyzed expressed RNAIII, suggesting that all of the
agr genes are functional. In addition, nucleotide sequence anal-
ysis of the RNAIII-coding regions of five representative KD
isolates suggested that the RNAIII molecules were not mu-
tated in these strains. Taken together, these results suggest that
the KD isolates are not bona fide agr-defective mutants.
In this study, a correlation was observed between the levels
of RNAIII and spa mRNA detected in each isolate in the early
exponential phase (Fig. 1B and 1C, t1). In the TSS isolates
which produced low levels of spa mRNA and SpA protein, high
levels of RNAIII were detected (Fig. 1B and 1C, lanes 8 and 9,
and data not shown). This suggests that the high levels of
RNAIII in these isolates may be suppressing the transcription
of the spa mRNA. In contrast, high levels of spa mRNA were
detected in early-exponential-phase cultures of the KD isolates
and in the few TSS isolates that expressed high levels of SpA
FIG. 3. Extracellular SpA secretion by KD and TSS isolates of S. aureus. The concentration of extracellular SpA in the supernatants of cultures grown to early and
late exponential phases (t1 and t2 in Fig. 1A, respectively) was determined by ELISA with biotinylated anti-SpA MAb, as described in the text. Each value represents
the mean of duplicate analyses of the same isolate. Strains RN4256, Cowan I, and Wood 46 were included in the study as controls. KD isolates were found to produce
significantly (P , 0.05) more extracellular SpA than TSS isolates as calculated by Student’s t test.
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(Fig. 1B and 1C, lanes 3 to 7, 10, and 11, and data not shown).
Furthermore, despite an obvious increase in the amounts of
RNAIII in the late-exponential-phase cultures of these iso-
lates, the amount of spa mRNA detected did not decrease
dramatically. This observation differs from the results of pre-
vious studies in which the spa mRNA was undetectable imme-
diately following the induction of RNAIII (47). The reason for
this discrepancy is unknown. How RNAIII suppresses spa gene
transcription has not been determined. It is possible that
RNAIII indirectly regulates this and other genes by its effect
on an as-yet-unidentified regulatory gene(s). As the RNAIII
expressed by the KD isolates appears to be intact (based on the
DNA sequence of the RNAIII-coding region), it is possible
that there may be a defect in one of these downstream regu-
latory genes such that spa mRNA transcription is not sup-
pressed in these strains. Alternatively, there may be a muta-
tion(s) in the spa promoter region that makes it less susceptible
to the activity of these negative regulators.
It should also be pointed out that other trans-acting regula-
tory loci may be involved in determining the level at which the
spa mRNA is transcribed or translated (7, 9, 16). In fact, it has
recently been reported that the sar regulatory locus suppresses
spa mRNA transcription by agr-dependent and agr-indepen-
dent mechanisms (6). The SarA protein is an activator of
RNAII and RNAIII transcription, binding to a nucleotide se-
quence between the P2 and P3 promoters of the agr locus (8,
10, 19). Thus, by optimizing the transcription of RNAIII, SarA
indirectly suppresses spa mRNA transcription. How the sar
locus suppresses spa mRNA transcription independently of agr
has not yet been determined. Given that in sarA-defective mu-
tants protease expression is increased and RNAIII transcription is
greatly reduced or absent (5, 8, 10, 19), it seems unlikely that the
KD isolates are defective in the sar regulatory locus.
It is clear from this and previous studies that the KD isolates
have similar phenotypes (34). In addition, our preliminary ob-
servations suggest that these isolates may also be very similar at
the genotypic level. We have noted that the chromosomal
restriction enzyme digestion profiles of these isolates are very
similar, if not identical. Furthermore, Southern hybridization
and PCR analyses of the spa and coagulase loci of these strains
suggest that they are highly conserved, encoding five N-termi-
nal IgG-binding repeats and four C-terminal fibrinogen-bind-
ing repeats, respectively (unpublished data). In addition, the
nucleotide sequence of a ca. 860-bp chromosomal region en-
compassing the RNAIII-coding region and flanking DNA was
identical in the KD isolates analyzed. Indeed, it is tempting to
speculate that the KD isolates may be clonal in origin, as is the
case for TSS isolates (39). The KD isolates used in this study
were collected from a variety of geographical locations within
the United States. A multicenter epidemiological study of KD
isolates using traditional typing methods, such as restriction
fragment length polymorphism and multilocus enzyme elec-
trophoresis analysis, or newer typing methods based on DNA
sequence analysis is warranted to further investigate the clon-
ality of these isolates.
It is a tantalizing possibility that the expression of high levels
of extracellular SpA, secreted locally by S. aureus isolates col-
onizing the gastrointestinal tract of patients, may contribute to
the symptoms of KD. It has been recently demonstrated that,
in addition to exhibiting immunoregulatory activities, SpA has
the ability to bind to von Willebrand factor, a protein that has
a central role in hemostasis and thrombogenesis (18). This
raises the exciting possibility that, in addition to inducing im-
mune activation, SpA could perturb host hemostasis and in-
crease the risk of vascular thrombosis, such as that associated
with KD. Interestingly, it has been noted that coronary com-
plications develop in some patients diagnosed with TSS (12,
49). Whether these patients are infected with S. aureus strains
that secrete high levels of SpA remains to be determined.
Significantly, such TSS isolates were observed in this study.
However, additional bacterial and host factors are likely to be
involved in determining whether a patient develops classical
TSS or KD (35). Investigation of the potential role of SpA in
the development of KD will require an animal model of this
disease in which the contribution of this and other factors can
be analyzed.
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